Dr. Shahid Ullah Khan (Dr. SK) recently concluded a highly successful international academic visit to Sanya China and Semarang Indonesia from 27 November to 7 December 2025, where he was invited as a distinguished speaker at multiple scientific and academic forums.

During this visit, Dr. Khan delivered a series of impactful talks under the themes: “The Beauty of Nanotechnology in Nanomedicine (with special focus on Triple-Negative Breast Cancer),” “From Kick-Start to Refinement: How to Write a Scientific Paper,” and “Nanotechnology as a Cutting-Edge Bridge Technology for Livestock.” His lectures were well received by faculty members, researchers, and international students, sparking vibrant discussions on innovation, research translation, and interdisciplinary collaboration.

In Indonesia, Dr. Khan also visited a leading Cancer and Stem Cell Research Center, where he engaged in in-depth scientific exchanges with renowned researchers and scientists from Japan, South Korea, MIT (USA), Thailand, and other countries. These interactions led to the sharing of novel ideas and invitations for future international collaborations.

The visit further provided valuable scientific insights in China, with promising discussions toward initiating new collaborative projects focused on the early detection of breast cancer using multi-omics approaches.

Reflecting on the journey, Dr. Khan described it as a truly memorable experience, enriched by meaningful academic exchange and the enthusiasm of international students. He expressed gratitude for the warm hospitality, productive discussions, and the wonderful moments captured throughout this inspiring academic tour.

Dr. Shahid Ullah Khan sincerely expresses his gratitude for the generous financial and institutional support provided by Dubai Medical University (DMU). He is especially thankful to the Research Associate Dean, the Dean of the College of Medicine, and the Vice Chancellor (Academic), DMU, whose encouragement and support made this international academic engagement possible. Their continued commitment to advancing research excellence and global collaboration is deeply appreciated.